The Philippines is the third-largest pharmaceutical market in ASEAN after Thailand and Indonesia. In 2019, total generic drug sales were PHP82.3 billion accounting for 63% of prescription sales and estimated to reach PHP110 Billion by 2024. The highest cost of medicines in the Philippines among ASEAN countries driving the purchase of more generic medicines than […]

Read More →

Myanmar’s pharmaceutical market size was $456 million in 2017 with a percapita pharma expenditure of $8.5 and expected to reach $656 million in 2022. Myanmar’s economy is growing continuously, and the pharmaceutical industry is predicted to quickly grow into a $1.12 billion industry in the future. In Myanmar, both non-communicable diseases and communicable diseases are […]

Read More →